{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T12:22:48Z","timestamp":1791289368833,"version":"4.3.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2015,5,7]],"date-time":"2015-05-07T00:00:00Z","timestamp":1430956800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2015,5,7]],"date-time":"2015-05-07T00:00:00Z","timestamp":1430956800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Necroptosis is a recently described Caspase 8-independent method of cell death that denotes organized cellular necrosis. The roles of RIP1 and RIP3 in mediating hepatocyte death from acute liver injury are incompletely defined. Effects of necroptosis blockade were studied by separately targeting RIP1 and RIP3 in diverse murine models of acute liver injury. Blockade of necroptosis had disparate effects on disease outcome depending on the precise etiology of liver injury and component of the necrosome targeted. In ConA-induced autoimmune hepatitis, RIP3 deletion was protective, whereas RIP1 inhibition exacerbated disease, accelerated animal death, and was associated with increased hepatocyte apoptosis. Conversely, in acetaminophen-mediated liver injury, blockade of either RIP1 or RIP3 was protective and was associated with lower NLRP3 inflammasome activation. Our work highlights the fact that diverse modes of acute liver injury have differing requirements for RIP1 and RIP3; moreover, within a single injury model, RIP1 and RIP3 blockade can have diametrically opposite effects on tissue damage, suggesting that interference with distinct components of the necrosome must be considered separately.<\/jats:p>","DOI":"10.1038\/cddis.2015.126","type":"journal-article","created":{"date-parts":[[2015,5,7]],"date-time":"2015-05-07T13:02:17Z","timestamp":1431003737000},"page":"e1759-e1759","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":114,"title":["Divergent effects of RIP1 or RIP3 blockade in murine models of acute liver injury"],"prefix":"10.1038","volume":"6","author":[{"given":"M","family":"Deutsch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C S","family":"Graffeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Rokosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Pansari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Ochi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E M","family":"Levie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Van Heerden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D M","family":"Tippens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Greco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Barilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Tomk\u00f6tter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C P","family":"Zambirinis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Avanzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Gulati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H L","family":"Pachter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Torres-Hernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Eisenthal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Daley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,5,7]]},"reference":[{"key":"BFcddis2015126_CR1","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1097\/MCG.0b013e31818a3854","volume":"43","author":"LJ Chun","year":"2009","unstructured":"Chun LJ, Tong MJ, Busuttil RW, Hiatt JR . Acetaminophen hepatotoxicity and acute liver failure. J Clin Gastroenterol 2009; 43: 342\u2013349.","journal-title":"J Clin Gastroenterol"},{"key":"BFcddis2015126_CR2","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1002\/hep.20948","volume":"42","author":"AM Larson","year":"2005","unstructured":"Larson AM, Polson J, Fontana RJ, Davern TJ, Lalani E, Hynan LS et al. Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study. Hepatology 2005; 42: 1364\u20131372.","journal-title":"Hepatology"},{"key":"BFcddis2015126_CR3","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1002\/hep.20293","volume":"40","author":"WM Lee","year":"2004","unstructured":"Lee WM . Acetaminophen and the U.S. Acute Liver Failure Study Group: lowering the risks of hepatic failure. Hepatology 2004; 40: 6\u20139.","journal-title":"Hepatology"},{"key":"BFcddis2015126_CR4","doi-asserted-by":"publisher","first-page":"3374","DOI":"10.3748\/wjg.14.3374","volume":"14","author":"DP Bogdanos","year":"2008","unstructured":"Bogdanos DP, Invernizzi P, Mackay IR, Vergani D . Autoimmune liver serology: current diagnostic and clinical challenges. World J Gastroenterol 2008; 14: 3374\u20133387.","journal-title":"World J Gastroenterol"},{"key":"BFcddis2015126_CR5","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1056\/NEJMra050408","volume":"354","author":"EL Krawitt","year":"2006","unstructured":"Krawitt EL . Autoimmune hepatitis. N Engl J Med 2006; 354: 54\u201366.","journal-title":"N Engl J Med"},{"key":"BFcddis2015126_CR6","doi-asserted-by":"publisher","first-page":"40","DOI":"10.7861\/clinmedicine.6-1-40","volume":"6","author":"N Murphy","year":"2006","unstructured":"Murphy N . An update in acute liver failure: when to transplant and the role of liver support devices. Clin Med 2006; 6: 40\u201346.","journal-title":"Clin Med"},{"key":"BFcddis2015126_CR7","doi-asserted-by":"publisher","first-page":"e31174","DOI":"10.1371\/journal.pone.0031174","volume":"7","author":"X Fang","year":"2012","unstructured":"Fang X, Wang R, Ma J, Ding Y, Shang W, Sun Z . Ameliorated ConA-induced hepatitis in the absence of PKC-theta. PLoS One 2012; 7: e31174.","journal-title":"PLoS One"},{"key":"BFcddis2015126_CR8","doi-asserted-by":"publisher","first-page":"2956","DOI":"10.1002\/eji.201343531","volume":"43","author":"M Higashimoto","year":"2013","unstructured":"Higashimoto M, Sakai Y, Takamura M, Usui S, Nasti A, Yoshida K et al. Adipose tissue derived stromal stem cell therapy in murine ConA-derived hepatitis is dependent on myeloid-lineage and CD4+ T-cell suppression. Eur J Immunol 2013; 43: 2956\u20132968.","journal-title":"Eur J Immunol"},{"key":"BFcddis2015126_CR9","doi-asserted-by":"publisher","first-page":"7047","DOI":"10.4049\/jimmunol.0900547","volume":"183","author":"M Nakaya","year":"2009","unstructured":"Nakaya M, Hashimoto M, Nakagawa R, Wakabayashi Y, Ishizaki T, Takada I et al. SOCS3 in T and NKT cells negatively regulates cytokine production and ameliorates ConA-induced hepatitis. J Immunol 2009; 183: 7047\u20137053.","journal-title":"J Immunol"},{"key":"BFcddis2015126_CR10","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1002\/hep.24429","volume":"54","author":"MK Connolly","year":"2011","unstructured":"Connolly MK, Ayo D, Malhotra A, Hackman M, Bedrosian AS, Ibrahim J et al. Dendritic cell depletion exacerbates acetaminophen hepatotoxicity. Hepatology 2011; 54: 959\u2013968.","journal-title":"Hepatology"},{"key":"BFcddis2015126_CR11","doi-asserted-by":"crossref","unstructured":"Han D, Shinohara M, Ybanez MD, Saberi B, Kaplowitz N . Signal transduction pathways involved in drug-induced liver injury. Handb Exp Pharmacol 2010: 267\u2013310.","DOI":"10.1007\/978-3-642-00663-0_10"},{"key":"BFcddis2015126_CR12","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1124\/dmd.31.12.1499","volume":"31","author":"LP James","year":"2003","unstructured":"James LP, Mayeux PR, Hinson JA . Acetaminophen-induced hepatotoxicity. Drug Metab Dispos 2003; 31: 1499\u20131506.","journal-title":"Drug Metab Dispos"},{"key":"BFcddis2015126_CR13","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1093\/toxsci\/kfi336","volume":"89","author":"H Jaeschke","year":"2006","unstructured":"Jaeschke H, Bajt ML . Intracellular signaling mechanisms of acetaminophen-induced liver cell death. Toxicol Sci 2006; 89: 31\u201341.","journal-title":"Toxicol Sci"},{"key":"BFcddis2015126_CR14","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1006\/taap.2002.9474","volume":"184","author":"CR Gardner","year":"2002","unstructured":"Gardner CR, Laskin JD, Dambach DM, Sacco M, Durham SK, Bruno MK et al. Reduced hepatotoxicity of acetaminophen in mice lacking inducible nitric oxide synthase: potential role of tumor necrosis factor-alpha and interleukin-10. Toxicol Appl Pharmacol 2002; 184: 27\u201336.","journal-title":"Toxicol Appl Pharmacol"},{"key":"BFcddis2015126_CR15","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1096\/fj.02-0046com","volume":"16","author":"Y Ishida","year":"2002","unstructured":"Ishida Y, Kondo T, Ohshima T, Fujiwara H, Iwakura Y, Mukaida N . A pivotal involvement of IFN-gamma in the pathogenesis of acetaminophen-induced acute liver injury. FASEB J 2002; 16: 1227\u20131236.","journal-title":"FASEB J"},{"key":"BFcddis2015126_CR16","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1053\/j.gastro.2004.08.053","volume":"127","author":"ZX Liu","year":"2004","unstructured":"Liu ZX, Govindarajan S, Kaplowitz N . Innate immune system plays a critical role in determining the progression and severity of acetaminophen hepatotoxicity. Gastroenterology 2004; 127: 1760\u20131774.","journal-title":"Gastroenterology"},{"key":"BFcddis2015126_CR17","first-page":"305","volume":"119","author":"AB Imaeda","year":"2009","unstructured":"Imaeda AB, Watanabe A, Sohail MA, Mahmood S, Mohamadnejad M, Sutterwala FS et al. Acetaminophen-induced hepatotoxicity in mice is dependent on Tlr9 and the Nalp3 inflammasome. J Clin Invest 2009; 119: 305\u2013314.","journal-title":"J Clin Invest"},{"key":"BFcddis2015126_CR18","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.taap.2011.03.001","volume":"252","author":"CD Williams","year":"2011","unstructured":"Williams CD, Antoine DJ, Shaw PJ, Benson C, Farhood A, Williams DP et al. Role of the Nalp3 inflammasome in acetaminophen-induced sterile inflammation and liver injury. Toxicol Appl Pharmacol 2011; 252: 289\u2013297.","journal-title":"Toxicol Appl Pharmacol"},{"issue":"Suppl 1","key":"BFcddis2015126_CR19","doi-asserted-by":"publisher","first-page":"S49","DOI":"10.1111\/j.1440-1746.2007.04962.x","volume":"22","author":"K Kon","year":"2007","unstructured":"Kon K, Ikejima K, Okumura K, Aoyama T, Arai K, Takei Y et al. Role of apoptosis in acetaminophen hepatotoxicity. J Gastroenterol Hepatol 2007; 22 (Suppl 1): S49\u2013S52.","journal-title":"J Gastroenterol Hepatol"},{"key":"BFcddis2015126_CR20","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.toxlet.2014.01.005","volume":"225","author":"YF Zhang","year":"2014","unstructured":"Zhang YF, He W, Zhang C, Liu XJ, Lu Y, Wang H et al. Role of receptor interacting protein (RIP)1 on apoptosis-inducing factor-mediated necroptosis during acetaminophen-evoked acute liver failure in mice. Toxicol Lett 2014; 225: 445\u2013453.","journal-title":"Toxicol Lett"},{"key":"BFcddis2015126_CR21","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/j.fob.2014.08.007","volume":"4","author":"K Takemoto","year":"2014","unstructured":"Takemoto K, Hatano E, Iwaisako K, Takeiri M, Noma N, Ohmae S et al. Necrostatin-1 protects against reactive oxygen species (ROS)-induced hepatotoxicity in acetaminophen-induced acute liver failure. FEBS Open Bio 2014; 4: 777\u2013787.","journal-title":"FEBS Open Bio"},{"key":"BFcddis2015126_CR22","doi-asserted-by":"publisher","first-page":"e1278","DOI":"10.1038\/cddis.2014.241","volume":"5","author":"JX Li","year":"2014","unstructured":"Li JX, Feng JM, Wang Y, Li XH, Chen XX, Su Y et al. The B-Raf(V600E) inhibitor dabrafenib selectively inhibits RIP3 and alleviates acetaminophen-induced liver injury. Cell Death Dis 2014; 5: e1278.","journal-title":"Cell Death Dis"},{"key":"BFcddis2015126_CR23","doi-asserted-by":"publisher","first-page":"962","DOI":"10.2353\/ajpath.2008.080358","volume":"173","author":"HM Ni","year":"2008","unstructured":"Ni HM, Chen X, Ding WX, Schuchmann M, Yin XM . Differential roles of JNK in ConA\/GalN and ConA-induced liver injury in mice. Am J Pathol 2008; 173: 962\u2013972.","journal-title":"Am J Pathol"},{"key":"BFcddis2015126_CR24","first-page":"706156","volume":"2013","author":"Y Zhou","year":"2013","unstructured":"Zhou Y, Dai W, Lin C, Wang F, He L, Shen M et al. Protective effects of necrostatin-1 against concanavalin A-induced acute hepatic injury in mice. Mediators Inflamm 2013; 2013: 706156.","journal-title":"Mediators Inflamm"},{"key":"BFcddis2015126_CR25","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1038\/cdd.2012.90","volume":"19","author":"S Jouan-Lanhouet","year":"2012","unstructured":"Jouan-Lanhouet S, Arshad MI, Piquet-Pellorce C, Martin-Chouly C, Le Moigne-Muller G, Van Herreweghe F et al. TRAIL induces necroptosis involving RIPK1\/RIPK3-dependent PARP-1 activation. Cell Death Differ 2012; 19: 2003\u20132014.","journal-title":"Cell Death Differ"},{"key":"BFcddis2015126_CR26","doi-asserted-by":"publisher","first-page":"e437","DOI":"10.1038\/cddis.2012.176","volume":"3","author":"N Takahashi","year":"2012","unstructured":"Takahashi N, Duprez L, Grootjans S, Cauwels A, Nerinckx W, DuHadaway JB et al. Necrostatin-1 analogues: critical issues on the specificity, activity and in vivo use in experimental disease models. Cell Death Dis 2012; 3: e437.","journal-title":"Cell Death Dis"},{"key":"BFcddis2015126_CR27","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/nchembio711","volume":"1","author":"A Degterev","year":"2005","unstructured":"Degterev A, Huang Z, Boyce M, Li Y, Jagtap P, Mizushima N et al. Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury. Nat Chem Biol 2005; 1: 112\u2013119.","journal-title":"Nat Chem Biol"},{"key":"BFcddis2015126_CR28","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1007\/s10495-009-0334-x","volume":"14","author":"W Han","year":"2009","unstructured":"Han W, Xie J, Li L, Liu Z, Hu X . Necrostatin-1 reverts shikonin-induced necroptosis to apoptosis. Apoptosis 2009; 14: 674\u2013686.","journal-title":"Apoptosis"},{"key":"BFcddis2015126_CR29","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1002\/hep.26547","volume":"58","author":"A Ramachandran","year":"2013","unstructured":"Ramachandran A, McGill MR, Xie Y, Ni HM, Ding WX, Jaeschke H . Receptor interacting protein kinase 3 is a critical early mediator of acetaminophen-induced hepatocyte necrosis in mice. Hepatology 2013; 58: 2099\u20132108.","journal-title":"Hepatology"},{"key":"BFcddis2015126_CR30","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.3748\/wjg.15.1025","volume":"15","author":"K Beland","year":"2009","unstructured":"Beland K, Lapierre P, Alvarez F . Influence of genes, sex, age and environment on the onset of autoimmune hepatitis. World J Gastroenterol 2009; 15: 1025\u20131034.","journal-title":"World J Gastroenterol"},{"key":"BFcddis2015126_CR31","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1111\/j.1572-0241.1999.01229.x","volume":"94","author":"PL Bittencourt","year":"1999","unstructured":"Bittencourt PL, Goldberg AC, Cancado EL, Porta G, Carrilho FJ, Farias AQ et al. Genetic heterogeneity in susceptibility to autoimmune hepatitis types 1 and 2. Am J Gastroenterol 1999; 94: 1906\u20131913.","journal-title":"Am J Gastroenterol"},{"key":"BFcddis2015126_CR32","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.cld.2010.07.003","volume":"14","author":"M Guindi","year":"2010","unstructured":"Guindi M . Histology of autoimmune hepatitis and its variants. Clin Liver Dis 2010; 14: 577\u2013590.","journal-title":"Clin Liver Dis"},{"key":"BFcddis2015126_CR33","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1055\/s-0029-1233531","volume":"29","author":"D Tripathi","year":"2009","unstructured":"Tripathi D, Neuberger J . Autoimmune hepatitis and liver transplantation: indications, results, and management of recurrent disease. Semin Liver Dis 2009; 29: 286\u2013296.","journal-title":"Semin Liver Dis"},{"key":"BFcddis2015126_CR34","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1007\/s00109-012-0938-4","volume":"90","author":"J Chen","year":"2012","unstructured":"Chen J, Duan L, Xiong A, Zhang H, Zheng F, Tan Z et al. Blockade of IL-33 ameliorates Con A-induced hepatic injury by reducing NKT cell activation and IFN-gamma production in mice. J Mol Med (Berl) 2012; 90: 1505\u20131515.","journal-title":"J Mol Med (Berl)"},{"key":"BFcddis2015126_CR35","doi-asserted-by":"publisher","first-page":"2302","DOI":"10.1172\/JCI31602","volume":"117","author":"RC Halder","year":"2007","unstructured":"Halder RC, Aguilera C, Maricic I, Kumar V . Type II NKT cell-mediated anergy induction in type I NKT cells prevents inflammatory liver disease. J Clin Invest 2007; 117: 2302\u20132312.","journal-title":"J Clin Invest"},{"key":"BFcddis2015126_CR36","doi-asserted-by":"publisher","first-page":"3768","DOI":"10.4049\/jimmunol.0800973","volume":"182","author":"W Jiang","year":"2009","unstructured":"Jiang W, Sun R, Zhou R, Wei H, Tian Z . TLR-9 activation aggravates concanavalin A-induced hepatitis via promoting accumulation and activation of liver CD4+ NKT cells. J Immunol 2009; 182: 3768\u20133774.","journal-title":"J Immunol"},{"key":"BFcddis2015126_CR37","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1038\/cdd.2012.133","volume":"20","author":"A Degterev","year":"2013","unstructured":"Degterev A, Maki JL, Yuan J . Activity and specificity of necrostatin-1, small-molecule inhibitor of RIP1 kinase. Cell Death Differ 2013; 20: 366.","journal-title":"Cell Death Differ"},{"key":"BFcddis2015126_CR38","doi-asserted-by":"publisher","first-page":"e320","DOI":"10.1038\/cddis.2012.64","volume":"3","author":"DE Christofferson","year":"2012","unstructured":"Christofferson DE, Li Y, Hitomi J, Zhou W, Upperman C, Zhu H et al. A novel role for RIP1 kinase in mediating TNFalpha production. Cell Death Dis 2012; 3: e320.","journal-title":"Cell Death Dis"},{"key":"BFcddis2015126_CR39","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.1021\/jm061016o","volume":"50","author":"PG Jagtap","year":"2007","unstructured":"Jagtap PG, Degterev A, Choi S, Keys H, Yuan J, Cuny GD . Structure-activity relationship study of tricyclic necroptosis inhibitors. J Med Chem 2007; 50: 1886\u20131895.","journal-title":"J Med Chem"},{"key":"BFcddis2015126_CR40","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.molcel.2014.10.021","volume":"56","author":"P Mandal","year":"2014","unstructured":"Mandal P, Berger SB, Pillay S, Moriwaki K, Huang C, Guo H et al. RIP3 induces apoptosis independent of pronecrotic kinase activity. Mol Cell 2014; 56: 481\u2013495.","journal-title":"Mol Cell"},{"key":"BFcddis2015126_CR41","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.cytogfr.2013.12.013","volume":"25","author":"K Moriwaki","year":"2014","unstructured":"Moriwaki K, Chan FK . Necrosis-dependent and independent signaling of the RIP kinases in inflammation. Cytokine Growth Factor Rev 2014; 25: 167\u2013174.","journal-title":"Cytokine Growth Factor Rev"},{"key":"BFcddis2015126_CR42","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.celrep.2013.08.045","volume":"5","author":"R Weinlich","year":"2013","unstructured":"Weinlich R, Oberst A, Dillon CP, Janke LJ, Milasta S, Lukens JR et al. Protective roles for caspase-8 and cFLIP in adult homeostasis. Cell Rep 2013; 5: 340\u2013348.","journal-title":"Cell Rep"},{"key":"BFcddis2015126_CR43","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1002\/hep.22556","volume":"48","author":"H Jaeschke","year":"2008","unstructured":"Jaeschke H . Innate immunity and acetaminophen-induced liver injury: why so many controversies? Hepatology 2008; 48: 699\u2013701.","journal-title":"Hepatology"},{"key":"BFcddis2015126_CR44","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1002\/eji.200535261","volume":"36","author":"Y Ishida","year":"2006","unstructured":"Ishida Y, Kondo T, Kimura A, Tsuneyama K, Takayasu T, Mukaida N . Opposite roles of neutrophils and macrophages in the pathogenesis of acetaminophen-induced acute liver injury. Eur J Immunol 2006; 36: 1028\u20131038.","journal-title":"Eur J Immunol"},{"key":"BFcddis2015126_CR45","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1021\/tx0255976","volume":"15","author":"C Ju","year":"2002","unstructured":"Ju C, Reilly TP, Bourdi M, Radonovich MF, Brady JN, George JW et al. Protective role of Kupffer cells in acetaminophen-induced hepatic injury in mice. Chem Res Toxicol 2002; 15: 1504\u20131513.","journal-title":"Chem Res Toxicol"},{"key":"BFcddis2015126_CR46","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1093\/toxsci\/54.2.509","volume":"54","author":"JA Lawson","year":"2000","unstructured":"Lawson JA, Farhood A, Hopper RD, Bajt ML, Jaeschke H . The hepatic inflammatory response after acetaminophen overdose: role of neutrophils. Toxicol Sci 2000; 54: 509\u2013516.","journal-title":"Toxicol Sci"},{"key":"BFcddis2015126_CR47","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1002\/hep.21175","volume":"43","author":"ZX Liu","year":"2006","unstructured":"Liu ZX, Han D, Gunawan B, Kaplowitz N . Neutrophil depletion protects against murine acetaminophen hepatotoxicity. Hepatology 2006; 43: 1220\u20131230.","journal-title":"Hepatology"},{"key":"BFcddis2015126_CR48","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1002\/hep.22400","volume":"48","author":"MJ Masson","year":"2008","unstructured":"Masson MJ, Carpenter LD, Graf ML, Pohl LR . Pathogenic role of natural killer T and natural killer cells in acetaminophen-induced liver injury in mice is dependent on the presence of dimethyl sulfoxide. Hepatology 2008; 48: 889\u2013897.","journal-title":"Hepatology"},{"key":"BFcddis2015126_CR49","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1002\/hep.510300104","volume":"30","author":"SL Michael","year":"1999","unstructured":"Michael SL, Pumford NR, Mayeux PR, Niesman MR, Hinson JA . Pretreatment of mice with macrophage inactivators decreases acetaminophen hepatotoxicity and the formation of reactive oxygen and nitrogen species. Hepatology 1999; 30: 186\u2013195.","journal-title":"Hepatology"},{"key":"BFcddis2015126_CR50","first-page":"3213","volume":"119","author":"MK Connolly","year":"2009","unstructured":"Connolly MK, Bedrosian AS, Mallen-St Clair J, Mitchell AP, Ibrahim J, Stroud A et al. In liver fibrosis, dendritic cells govern hepatic inflammation in mice via TNF-alpha. J Clin Invest 2009; 119: 3213\u20133225.","journal-title":"J Clin Invest"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/cddis2015126.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/cddis2015126","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/cddis2015126.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T10:02:22Z","timestamp":1672912942000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/cddis2015126"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,7]]},"references-count":50,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2015,5]]}},"alternative-id":["BFcddis2015126"],"URL":"https:\/\/doi.org\/10.1038\/cddis.2015.126","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,7]]},"assertion":[{"value":"23 June 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2015","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2015","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2015","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}